Mad in America
JULY 13, 2024
But Ghaemi wants to claim that lithium is special—that it does more than target symptom mechanisms, it modifies the disease process that underpins bipolar disorder. More people than ever are using psychiatric drugs, such as antidepressants, and seeking psychiatric diagnoses including depression, bipolar disorder, ADHD and autism.
Mad in America
FEBRUARY 20, 2024
Stephenson and a team of researchers from various academic and pharmaceutical institutions, including the University of Virginia School of Medicine. Maelys Touya was an employee of Lundbeck LLC, and Lambros Chrones was an employee of Takeda Pharmaceuticals U.S.A., The study was authored by Judith J. Additionally, Anita H.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mad in America
JANUARY 4, 2025
In our 2015 book Psychiatry Under the Influence , Lisa Cosgrove and I wrote about the STAR*D scandal in depth, as it served as an example of the institutional corruption in psychiatry due to pharmaceutical interests and psychiatrys own guild interests. The 12 STAR*D authors listed a collective total of 151 ties to pharmaceutical companies.
Mad in America
DECEMBER 20, 2023
For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. Moore: The last couple of questions are related to the pharmaceutical industry. Then we got juvenile bipolar disorder. How about the kids?
Mad in America
NOVEMBER 7, 2023
The clinician might regard some treatment options as ill-suited to that particular patient: ketamine, for example, in a patient with bipolar disorder (because research has only just recently been expanded to include bipolar depression). Not the right starting point for creating a good placebo effect.
Mad in America
OCTOBER 30, 2023
Whitaker found that psychosis pills, depression pills and benzodiazepines worsen long-term outcomes, and that bipolar disorder, which is regularly treated with polypharmacy, runs a much more chronic course than manic depressive disorder—the diagnostic precursor to bipolar—once did. This is mendacious.
Mad in America
JANUARY 9, 2024
Academics even boast that EBM shackles the pharmaceutical industry. A century ago, Paul Ehrlich, whose research helped create the modern pharmaceutical industry, saw the ideal medicine as a Magic Bullet, a drug that hits a target without causing collateral damage. Doctors adamantly insist they are not influenced by adverts.
Expert insights. Personalized for you.
145 
Let's personalize your content